# George M. Rodgers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/george-m-rodgers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,031 |
| Field | Blood Coagulation and Thrombosis Mechanisms |
| h-index | 46 |
| i10-index | 123 |
| Last Known Institution | University of Utah |
| OpenAlex ID | https://openalex.org/A5002698865 |
| ORCID iD | 0000-0003-1234-0128 |
| Works | 286 |

## Researcher papers

- [Preeclampsia: An endothelial cell disorder](https://scholariq.org/papers/preeclampsia-an-endothelial-cell-disorder/)
- [Evidence of increased angiogenesis in patients with acute myeloid leukemia](https://scholariq.org/papers/evidence-of-increased-angiogenesis-in-patients-with-acute-myeloid-leukemia/)
- [Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.](https://scholariq.org/papers/activation-of-endogenous-factor-v-by-a-homocysteine-induced-vascular-endothelial/)
- [Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease](https://scholariq.org/papers/subcutaneous-enoxaparin-once-or-twice-daily-compared-with-intravenous/)
- [Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.](https://scholariq.org/papers/homocysteine-a-risk-factor-for-premature-vascular-disease-and-thrombosis-induces/)
- [The D‐dimer assay](https://scholariq.org/papers/the-d-dimer-assay/)
- [Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells](https://scholariq.org/papers/preeclampsia-is-associated-with-a-serum-factor-cytotoxic-to-human-endothelial/)
- [Diagnosis and treatment of cancer‐related anemia](https://scholariq.org/papers/diagnosis-and-treatment-of-cancer-related-anemia/)
- [Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis](https://scholariq.org/papers/homocysteinemia-association-of-a-metabolic-disorder-with-vascular-disease-and/)
- [Cancer- and Chemotherapy-Induced Anemia](https://scholariq.org/papers/cancer-and-chemotherapy-induced-anemia/)
- [Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe<sup>2+</sup>?](https://scholariq.org/papers/total-dose-iron-dextran-infusion-in-cancer-patients-is-it-safe-sup-2-sup/)

## Researcher topics

- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Researcher university

- [University of Utah](https://scholariq.org/institutions/university-of-utah/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.